The role of PSMA PET/CT in staging patients with intermediate-risk prostate cancer. Bonaddio J, Carll J, Eapen R, Sathianathen N, et al. BJU Int 2025 Sep 30. doi: 10.1111/bju.70015.

Read + Share

Amedeo Smart

Independent Medical Education

Bonaddio J, Carll J, Eapen R, Sathianathen N, et al. The role of PSMA PET/CT in staging patients with intermediate-risk prostate cancer. BJU Int 2025 Sep 30. doi: 10.1111/bju.70015.
PMID: 41025962